It's tough to figure out what the baseline survival of aGVHD is in the paediatric population - especially since many of the historic figures are now years/decades old - and management has changed significantly since then.
This is why it is important to have proper controls, because using historic controls is fraught with potential error
It's tough to figure out what the baseline survival of...
-
- There are more pages in this discussion • 881 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.015(1.38%) |
Mkt cap ! $1.255B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.12 | $1.07 | $1.752M | 1.599M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 20252 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 25314 | 7 |
View Market Depth
| Last trade - 12.46pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |